Wound Care Report
Nov. 12, 2014

Regenerative medicine may offer new standard of advanced treatment for foot, leg ulcers
Macrocure Ltd. via News-Medical.Net
These are exciting times for regenerative medicine. Unlike conventional medicines, the regenerative approach can potentially work to restore the lost functionality of tissues or organs — the major reason for intensive focus on research and development in the field. The global market is projected to reach $67.6 billion by 2020, up from $16.4 billion in 2013, according to a report released in summer 2014 by market intelligence company Allied Market Research.More

Save the date: March 25-29, 2015
APWCA
Join us for the 14th Annual APWCA National Clinical Conference
March 25-29
Loews Philadelphia Hotel

Register online now and save.More

Research continues on low-level laser therapy as post-surgery treatment
Chiropractic Economics
Low-level laser therapy has a wide array of applications. As a therapy with no known side effects and few contraindications, clinicians are experimenting with using it as a treatment for many types of conditions. One of the biggest issues with using LLLT successfully to improve patient outcomes is that there are so many types of lasers, parameters and protocols. One area that has seen consistently positive results is the use of LLLT to treat post-surgical wounds.More

What long-term care nursing staff can do to prepare for state surveys
Wound Source
Today, more than ever, those working in long-term care facilities feel like they would rather mysteriously vanish than be working the day of the state survey process. Facilities must be prepared to demonstrate compliance with federal regulations at all times to minimize any risk of citation. It should be your expectation to do the right thing every day, but menacing surveys need to be managed.More

Closing the gap for generic nanomedicines
Chemical & Engineering News
In October 2011, drug shortages were such a pressing issue in the U.S. that President Barack Obama issued an executive order urging the Food & Drug Administration to streamline the approval process for new therapeutics that could fill the voids. One of the more noticeable voids was in the supply of Doxil, a nanoparticle chemotherapy drug. To curb this shortage, FDA authorized the temporary importation of an Indian Doxil copycat called Lipodox in February 2012. In keeping with the executive order, the agency evaluated and approved the drug formulation within a year, roughly one-third of the time it takes for an average generic medicine to receive approval. Doxorubicin hydrochloride liposome injection became what many consider to be the first generic nanodrug approved in the U.S.More

Obama administration predicts significantly lower healthcare enrollment
The Washington Post
The Obama administration recently announced that it expects the number of people who will gain health coverage in the next year through the Affordable Care Act's insurance marketplaces to be significantly fewer than previous government predictions. Health and Human Services officials said that 9 to 9.9 million Americans — as much as 30 percent below other estimates — will have insurance by the end of 2015 through fledgling federal and state insurance exchanges intended for people who cannot get affordable coverage through a job.More

6 medieval medical practices you won't believe doctors still use today
Healthcare Global
Sometimes, it's best to stick with what works, even in medicine. While there is always innovation in the healthcare industry, there are certain practices that doctors hold on to simply because they work. Here are the six oldest medical practices that doctors are still using today.More